Evidence map›Paper›PMID 40236225›Full record

ArticlebioRxiv : the preprint server for biology2025

Transcriptional downregulation of rhodopsin is associated with desensitization of rods to light-induced damage in a murine model of retinitis pigmentosa.

Shimpei Takita, Hemavathy Harikrishnan, Masaru Miyagi, Yoshikazu Imanishi

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Shimpei Takita
Hemavathy Harikrishnan
Masaru Miyagi
Yoshikazu ImanishiORCID 0000-0003-4696-4836

Funding

Photoreceptor dysfunction associated with rhodopsin mislocalizationR01EY028884 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI IMANISHI, YOSHIKAZU · 2018 to 2021
$1.6M
Proteostasis modulation in inherited blinding disordersR01EY029680 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI IMANISHI, YOSHIKAZU · 2019 to 2022
$1.5M
NEI NIH HHS R01 EY028884NEI NIH HHS R01 EY029680
6 · The paper itself

Abstract

Class I rhodopsin mutations are known for some of the most severe forms of vision impairments in dominantly inherited rhodopsin retinitis pigmentosa. They disrupt the VxPx transport signal, which is required for the proper localization of rhodopsin to the outer segments. While various studies have focused on the light-dependent toxicity of mutant rhodopsin, it remains unclear whether and how these mutations exert dominant-negative effects. Using the class I

Identifiers

PMID40236225
PMCPMC11996569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.